Evaluation of serum (1 → 3)-β-d-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors

Routine Use of a Protease Zymogen-Based Colorimetric Assay for the Detection of Beta-Glucan and its Role in Clinical Practice

(2017) C. Farina et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

An Antibody Reactivity-Based Assay for Diagnosis of Invasive Candidiasis Using Protein Array

(2017) A. Ardizzoni et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

Clinical performance of a commercial real-time PCR assay for Aspergillus DNA detection in serum samples from high-risk patients: comparison with a galactomannan enzyme immunoassay

(2014) P. Pini et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Use and Limits of (1-3)- -D-Glucan Assay (Fungitell), Compared to Galactomannan Determination (Platelia Aspergillus), for Diagnosis of Invasive Aspergillosis

(2014) A. Sulahian et al.   JOURNAL OF CLINICAL MICROBIOLOGY

β-Glucan Antigenemia Anticipates Diagnosis of Blood Culture–Negative Intraabdominal Candidiasis

(2013) Frederic Tissot et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Finding the “Missing 50%” of Invasive Candidiasis: How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care

(2013) Cornelius J. Clancy et al.   CLINICAL INFECTIOUS DISEASES

Candidaemia in internal medicine departments: the burden of a rising problem

(2013) M. Bassetti et al.   CLINICAL MICROBIOLOGY AND INFECTION

Surviving Sepsis Campaign

(2013) R. Phillip Dellinger et al.   CRITICAL CARE MEDICINE

An Italian consensus for invasive candidiasis management (ITALIC)

(2013) L. Scudeller et al.   INFECTION

A prospective analysis of invasive candidiasis following cardiac surgery: Severity markers are predictive

(2013) Christina Forstner et al.   JOURNAL OF INFECTION

A Risk Prediction Score for Invasive Mold Disease in Patients with Hematological Malignancies

(2013) Marta Stanzani et al.   PLoS One

(1,3)- -D-Glucan as a Prognostic Marker of Treatment Response in Invasive Candidiasis

(2012) S. Jaijakul et al.   CLINICAL INFECTIOUS DISEASES

ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures

(2012) M. Cuenca-Estrella et al.   CLINICAL MICROBIOLOGY AND INFECTION

Correlation of Clinical Outcomes with β-Glucan Levels in Patients with Invasive Candidiasis

(2012) Charles R. Sims et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Systematic Review and Meta-Analysis of Detecting Galactomannan in Bronchoalveolar Lavage Fluid for Diagnosing Invasive Aspergillosis

(2012) Mingxiang Zou et al.   PLoS One

β-D-glucan Surveillance with Preemptive Anidulafungin for Invasive Candidiasis in Intensive Care Unit Patients: A Randomized Pilot Study

(2012) Kimberly E. Hanson et al.   PLoS One

Serum (1 → 3)-β-D-glucan levels (Fungitell assay) is not useful as a screening test for recipients of an allogeneic HSCT while on immunoglobulin replacement

(2011) U Duffner et al.   BONE MARROW TRANSPLANTATION

ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients

(2011) O Marchetti et al.   BONE MARROW TRANSPLANTATION

Clinical Performance of the (1,3)-β-d-Glucan Assay in Early Diagnosis of Nosocomial Candida Bloodstream Infections

(2011) Valerio Del Bono et al.   Clinical and Vaccine Immunology

 -D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis

(2011) D. E. Karageorgopoulos et al.   CLINICAL INFECTIOUS DISEASES

 -Glucan Antigenemia Assay for the Diagnosis of Invasive Fungal Infections in Patients With Hematological Malignancies: A Systematic Review and Meta-Analysis of Cohort Studies From the Third European Conference on Infections in Leukemia (ECIL-3)

(2011) F. Lamoth et al.   CLINICAL INFECTIOUS DISEASES

Multicenter, Prospective Clinical Evaluation of Respiratory Samples from Subjects at Risk for Pneumocystis jirovecii Infection by Use of a Commercial Real-Time PCR Assay

(2011) P. M. Hauser et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Diagnosis of Invasive Aspergillosis by a Commercial Real-Time PCR Assay for Aspergillus DNA in Bronchoalveolar Lavage Fluid Samples from High-Risk Patients Compared to a Galactomannan Enzyme Immunoassay

(2011) R. Torelli et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Diagnostic Accuracy of Serum 1,3-β-d-Glucan for Pneumocystis jiroveci Pneumonia, Invasive Candidiasis, and Invasive Aspergillosis: Systematic Review and Meta-Analysis

(2011) Akira Onishi et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Prospective Survey of (1->3)- -D-Glucan and Its Relationship to Invasive Candidiasis in the Surgical Intensive Care Unit Setting

(2010) J. F. Mohr et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Kinetic Patterns of Candida albicans Germ Tube Antibody in Critically Ill Patients: Influence on Mortality

(2009) R. Zaragoza et al.   Clinical and Vaccine Immunology

Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study

(2009) Cristóbal León et al.   CRITICAL CARE MEDICINE

Reappraisal of the Serum (1→3)‐β‐D‐Glucan Assay for the Diagnosis of Invasive Fungal Infections—A Study Based on Autopsy Cases from 6 Years

(2008) Taminori Obayashi et al.   CLINICAL INFECTIOUS DISEASES

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES